Non motor subtypes and Parkinson's disease

A Sauerbier, P Jenner, A Todorova… - Parkinsonism & related …, 2016 - Elsevier
Non motor symptoms (NMS) represent a significant burden in Parkinson's disease (PD) with
numerous studies highlighting the importance of NMS both in “pre-motor” phase of PD as …

New clinical trials for nonmotor manifestations of Parkinson's disease

A Schrag, A Sauerbier, KR Chaudhuri - Movement Disorders, 2015 - Wiley Online Library
Nonmotor manifestations in Parkinson's disease (PD) encompass a range of clinical
features, including neuropsychiatric problems, autonomic dysfunction, sleep disorders …

[HTML][HTML] The range and nature of non-motor symptoms in drug-naive Parkinson's disease patients: a state-of-the-art systematic review

P Zis, R Erro, CC Walton, A Sauerbier… - npj Parkinson's …, 2015 - nature.com
Non-motor symptoms (NMS) are a key component of Parkinson's disease (PD). A range of
NMS, most notably impaired sense of smell, sleep dysfunction, and dysautonomia are …

EuroInf 2: subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease

HS Dafsari, P Martinez‐Martin, A Rizos… - Movement …, 2019 - Wiley Online Library
Objective Real‐life observational report of clinical efficacy of bilateral subthalamic
stimulation (STN‐DBS), apomorphine (APO), and intrajejunal levodopa infusion (IJLI) on …

[HTML][HTML] Gender gap in deep brain stimulation for Parkinson's disease

ST Jost, L Strobel, A Rizos, PA Loehrer… - npj Parkinson's …, 2022 - nature.com
Previous studies have shown less access to deep brain stimulation (DBS) for Parkinson's
disease (PD) in women compared to men raising concerns about a potential gender gap …

The European Academy of Neurology COVID‐19 registry (ENERGY): an international instrument for surveillance of neurological complications in patients with COVID …

E Beghi, R Helbok, M Crean, SHY Chou… - European Journal of …, 2021 - Wiley Online Library
The COVID‐19 pandemic is a global public health issue. Neurological complications have
been reported in up to one‐third of affected cases, but their distribution varies significantly in …

[HTML][HTML] New concepts in the pathogenesis and presentation of Parkinson's disease

A Sauerbier, MA Qamar, T Rajah… - Clinical Medicine, 2016 - ncbi.nlm.nih.gov
Parkinson's disease (PD) was first described by James Parkinson in 1817. He noted the
complex nature of this condition and that non-motor symptoms (NMS) underpinned the …

[HTML][HTML] Non-oral dopaminergic therapies for Parkinson's disease: current treatments and the future

K Ray Chaudhuri, MA Qamar, T Rajah… - npj Parkinson's …, 2016 - nature.com
Dysfunction of the gastrointestinal tract has now been recognized to affect all stages of
Parkinson's disease (PD). The consequences lead to problems with absorption of oral …

[HTML][HTML] Personalised advanced therapies in Parkinson's disease: the role of non-motor symptoms profile

V Leta, HS Dafsari, A Sauerbier, V Metta… - Journal of personalized …, 2021 - mdpi.com
Device-aided therapies, including levodopa-carbidopa intestinal gel infusion, apomorphine
subcutaneous infusion, and deep brain stimulation, are available in many countries for the …

Nonmotor symptoms and focal cervical dystonia: observations from 102 patients

L Klingelhoefer, D Martino, P Martinez-Martin… - Basal Ganglia, 2014 - Elsevier
Introduction Evidence is emerging that nonmotor symptoms (NMS) such as neuropsychiatric,
sensory and sleep disturbances play an important role in dystonia. Methods In this …